Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our recommendation for VRTX stock.

Google has surged ahead in the enterprise AI race after perceived stumbles. VentureBeat details the Gemini models, TPU ...

Securiti, the pioneer of the Data+AI Command Center, today announced its recognition as the highest-rated Data Security Posture Management (DSPM) solution by GigaOm. In the 2025 edition of the GigaOm ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

In the latest trading session, Vertex Pharmaceuticals (VRTX ... has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual ...

Victory Capital Management Inc. raised its stake in shares of Vertex by 406.9% during the third quarter. Victory Capital Management Inc. now owns 34,386 shares of the company’s stock valued at $ ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

Colin Carroll, the chief of staff of Deputy Secretary of Defense Steve Feinberg, has been placed on administrative leave, two defense sources said Wednesday, the third such appointee to be placed ...

In the default model, the graph representing each individual enhancer can be arbitrarily complicated. To show how the ABC Score formula can arise from the default model, we need to impose the further ...

SPOTSYLVANIA COUNTY, Va. — The parents of a third-grade student at Lee Hill Elementary School in Spotsylvania County were arrested and charged after a handgun discharged in their child's ...

VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of thePhase 1/2 VX-264 (cells + device) study and the planned analysis at Day 90 for Part B. In Part B of the study ...